Login
Home / ARX.AX : ASX
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Aroa Biosurgery Limited

AUD 0.54 -$0.19 (-26.03%)
ASX · 16 Sep 2026 06:10 UTC
Previous Close
AUD 0.56
Day Range
AUD 0.54AUD 0.56
Year Range
AUD 0.49AUD 0.8
Market Cap
186.56M
AVG Volume
257.41K
Trailing/Forward PE
29.67/38.13
PEG ratio
0.2
Dividend Yield
-
Next Earnings Date
2026-11-24
Primary Exchange
Australian Securities ExchangeAU
Revenue (AUD)
020M40M60M80M20242025
Net Income (AUD)
-15M-10M-5M020242025
Operating Income (AUD)
-15M-10M-5M020242025
EBITDA (AUD)
-10M-7.5M-5M-2.5M02.5M20242025
Cash Flows (AUD)
-20M-15M-10M-5M020242025
EPS (AUD)
-0.04-0.03-0.02-0.01020242025
Expenses (AUD)
025M50M75M100MR&DSG&ACapex20242025
Cash & Debt (AUD)
010M20M30MCashShort Term Debt20242025
Debt ratios
00.511.520242025
Margins
0%25%50%75%100%20242025
Return on Capital
-15%-10%-5%0%20242025
Shares Outstanding
0100M200M300M400M20242025
Book Value Per Share (AUD)
00.10.20.320242025
Total Assets (AUD)
050M100M150M20242025
PE Ratio
0100200300med 218.1Apr 26May 26May 26Jun 26Jul 26Aug 26Sep 26
Free Cash Flow Yield
-10%-5%0%5%10%med -1.95%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
1234med 2.47Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
0200400600med 62.04Jul 25Oct 25Dec 25Feb 26May 26Jul 26Sep 26
Price/Operating Cashflow
0255075100125med 24.56Jan 26Feb 26Apr 26May 26Jun 26Aug 26Sep 26
Price to Book
1.522.533.5med 2.56Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Aroa Biosurgery Limited
ARX.AX
Stockpicker

Video analysis: ARX.AX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ARX.AX

Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction

gurufocus.com · 6 Sep 2026

Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction

Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction PR Newswire

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.